JUP and colorectal cancer: Inhibitor of β‐catenin and T‐cell factor (ICAT) promotes colorectal cancer (CRC) cell migration and invasion by interacting with the junction plakoglobin (JUP) and via the NF‐κB signaling pathway in CRC.